Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-08-26

FDA Approved: INOMAX — Supplemental Application (INO Therapeutics LLC)

View source ↗

Summary

FDA approved a supplemental application for INOMAX (nitric oxide) from INO Therapeutics LLC. The approval updates the existing NDA for INOMAX, potentially impac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INOmax (nitric oxide)

Snippet

SUPPL AP for INOMAX (NITRIC OXIDE)